News

Three Indian Companies Offering Clinical Imaging Solutions Utilizing AI

NDM News Network

International Data Corporation (IDC ) has published a new IDC Innovators report profiling three companies that provide clinical imaging solutions utilizing artificial intelligence (AI) for use in the healthcare sector. The three companies are: Qure.ai, Aindra Systems, and Niramai.ai.

Imaging plays an important role in detecting clinical lesions that requires human attention and are time-consuming when it comes to scanning each image, among the multitude of images available.

“Leveraging AI helps in delivering improved clinical outcomes by automating the detection of abnormalities in images specifically that miss the human eye. This helps in quicker decision making with fewer diagnostics errors. With the increasing healthcare data, the industry has started gaining pace to move from a subjective perceptual skill to more objective science,” said Rishu Sharma, Principal Analyst, Cloud & AI, IDC India.

The India market is witnessing new-age vendors that help hospitals and healthcare agencies in automating workflows, increase the rate at which high-volume and high-resolution images are handled, and enhance overall patients’ and physicians’ experience.

“Artificial Intelligence and machine learning technologies have increased the clinical imaging adoption to get better, stronger, faster and more accurate results while reducing the time of experts. Clinical imaging's present and future is AIML technologies plus humans as healthcare industry expects AI to extract insights from data to deliver actionable insights,” said Swapnil Shende, Senior Market Analyst for AI at IDC India.

The new report, IDC Innovators: Clinical Imaging Solutions in Healthcare, India, 2019 (IDC #AP45864219 ), profiles three emerging vendors that offer clinical Imaging solutions utilizing AI for healthcare in India.

  • ai builds deep neural networks which understand and interpret medical images more accurately and perform automated task by enabling machines to perform routine diagnostic tasks.
  • Aindra Systems applies AI-based computational pathology to digitally analyze the sample and detect cancer at the point of care.
  • aiprovides an AI-powered patented technology to detect early-stage breast cancer and perform noncontact, non-invasive, and radiation-free screening.